Literature DB >> 12588227

Congenital dermatofibrosarcoma protuberans: variability in presentation.

Jill M Weinstein1, Beth A Drolet, Nancy B Esterly, Maureen Rogers, Bruce S Bauer, Annette M Wagner, Anthony J Mancini.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is an uncommon low-grade fibrohistiocytic tumor that usually occurs on the trunk or proximal extremities and typically appears during the second to fifth decade of life. It most commonly begins as a red-blue plaque that grows slowly and ultimately becomes nodular. The tumor is associated with a high recurrence rate but low metastatic potential. It rarely presents in childhood and is even more rarely present at birth. The clinical diagnosis of DFSP in infancy or childhood may be difficult because, in its early stages, the tumor often resembles a vascular birthmark. OBSERVATIONS: We studied 6 patients with congenital DFSP who were initially thought to have other diagnoses, highlighting the potential clinical variability in presentation. Half of the cases in this series occurred in areas of the body outside of the typically reported distribution pattern of acquired DFSP and in locations that, therefore, may not arouse suspicion of congenital DFSP.
CONCLUSIONS: Given the aggressive local potential and high recurrence rate of DFSP, early diagnosis is preferable to facilitate appropriate excision. We recommend that any infant or child presenting with a cutaneous plaque or nodule, even congenital, that does not have characteristic or diagnostic clinical features undergo tissue biopsy for histologic evaluation.

Entities:  

Mesh:

Year:  2003        PMID: 12588227     DOI: 10.1001/archderm.139.2.207

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

1.  Congenital Dermatofibrosarcoma Protuberans: A Case Report and Literature Review.

Authors:  Hyun Ho Han; Soo Yeon Lim; Young Min Park; Jong Won Rhie
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

2.  Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.

Authors:  Chimene Kesserwan; Robert Sokolic; Edward W Cowen; Elizabeth Garabedian; Kerstin Heselmeyer-Haddad; Chyi-Chia Richard Lee; Stefania Pittaluga; Clarymar Ortiz; Kristin Baird; Dolores Lopez-Terrada; Julia Bridge; Alan S Wayne; Fabio Candotti
Journal:  J Allergy Clin Immunol       Date:  2011-12-06       Impact factor: 10.793

3.  Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change.

Authors:  W Gu; A Ogose; H Kawashima; H Umezu; N Kudo; T Hotta; N Endo
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

Review 4.  Dermatofibrosarcoma Protuberans in Children.

Authors:  Aseel Sleiwah; Thomas C Wright; Thomas Chapman; Adam Dangoor; Francesca Maggiani; Rachel Clancy
Journal:  Curr Treat Options Oncol       Date:  2022-04-08

Review 5.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

6.  Clinical Features, Pathological Findings and Treatment of Recurrent Dermatofibrosarcoma Protuberans.

Authors:  Yanan Li; Chuan Wang; Bo Xiang; Siyuan Chen; Li Li; Yi Ji
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

7.  Dermatofibrosarcoma protuberans in a child: a case report.

Authors:  Prashant Goyal; Shelly Sehgal; Sompal Singh; Shalabh Rastogi
Journal:  Case Rep Dermatol Med       Date:  2012-12-18

8.  A rare giant scalp dermatofibrosarcoma protuberans.

Authors:  Muhammad Z Arifin; Farid Yudoyono; Rully H Dahlan; Bethy S Hernowo; Agung B Sutiono; Ahmad Faried
Journal:  Surg Neurol Int       Date:  2014-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.